Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 43, 2013, Pages 17474-17479

  Kawamura, Kazuhiro ^a,b   Cheng, Yuan ^c   Suzuki, Nao ^a   Deguchi, Masashi ^c   Sato, Yorino ^a,c   Takae, Seido ^a,c   Ho, Chi Hong ^c   Kawamura, Nanami ^a,b   Tamura, Midori ^a   Hashimoto, Shu ^d   Sugishita, Yodo ^a   Morimoto, Yoshiharu ^d   Hosoi, Yoshihiko ^e   Yoshioka, Nobuhito ^a   Ishizuka, Bunpei ^a   Hsueh, Aaron J ^c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IVF Namba Clinic   (Japan)

^e KINKI UNIVERSITY   (Japan)

Author keywords

Aging; CCN2; Ovary; PTEN; YAP

Indexed keywords

CHORIONIC GONADOTROPIN; CONNECTIVE TISSUE GROWTH FACTOR; F ACTIN; G ACTIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE INHIBITOR;

ACTIN POLYMERIZATION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; CONTROLLED STUDY; CORPUS LUTEUM; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; ENZYME ACTIVATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HIPPO SIGNALING PATHWAY; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY INSUFFICIENCY; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSVAGINAL ECHOGRAPHY;

AGING; CCN2; OVARY; PTEN; YAP;

ADULT; ANIMALS; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOBLOTTING; INFANT, NEWBORN; INFERTILITY, FEMALE; MALE; MICE; MICE, SCID; OOCYTE RETRIEVAL; OVARIAN FOLLICLE; PREGNANCY; PREGNANCY OUTCOME; PRIMARY OVARIAN INSUFFICIENCY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84886415388     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1312830110     Document Type: Article

References (41)

1. Broekmans FJ, et al. (2006) PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113(10):1210-1217.
2. Nelson LM (2009) Clinical practice. Primary ovarian insufficiency. N Engl J Med 360(6): 606-614.
3. De Vos M, Devroey P, Fauser BC (2010) Primary ovarian insufficiency. Lancet 376(9744):911-921.
4. Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181.
5. Farquhar C, Brown J, Marjoribanks J (2012) Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 6:CD001122.
6. Donnez J, et al. (2011) Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 43(6):437-450.
7. Pan D (2007) Hippo signaling in organ size control. Genes Dev 21(8):886-897.
8. Halder G, Johnson RL (2011) Hippo signaling: Growth control and beyond. Development 138(1):9-22.
9. Hergovich A (2012) Mammalian Hippo signalling: A kinase network regulated by protein-protein interactions. Biochem Soc Trans 40(1):124-128.
10. Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: Structurefunction relationships. Trends Biochem Sci 33(10):461-473.
11. Liu-Chittenden Y, et al. (2012) Genetic and pharmacological disruption of the TEADYAP complex suppresses the oncogenic activity of YAP. Genes Dev 26(12):1300-1305.
12. Reddy P, et al. (2008) Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 319(5863):611-613.
13. Fan HY, Liu Z, Cahill N, Richards JS (2008) Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Mol Endocrinol 22(9):2128-2140.
14. Li J, et al. (2010) Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci USA 107(22):10280-10284.
15. Sansores-Garcia L, et al. (2011) Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J 30(12):2325-2335.
16. Fernández BG, et al. (2011) Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 138(11):2337-2346.
17. Zhao B, Tumaneng K, Guan KL (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13(8):877-883.
18. Suzuki N, et al. (2012) Assessment of long-term function of heterotopic transplants of vitrified ovarian tissue in cynomolgus monkeys. Hum Reprod 27(8):2420-2429.
19. McGee EA, Hsueh AJ (2000) Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21(2):200-214.
20. Adhikari D, et al. (2012) The safe use of a PTEN inhibitor for the activation of dormant mouse primordial follicles and generation of fertilizable eggs. PLoS ONE 7(6):e39034.
21. Lu L, et al. (2010) Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 107(4):1437-1442.
22. Lee KP, et al. (2010) The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 107(18): 8248-8253.
23. Heallen T, et al. (2011) Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332(6028):458-461.
24. St John MA, et al. (1999) Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 21(2):182-186.
25. Pisarska MD, Kuo FT, Bentsi-Barnes IK, Khan S, Barlow GM (2010) LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity. Am J Physiol Endocrinol Metab 299(1):E101-E109.
26. Li T, et al. (2012) Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome. J Med Genet 49(4):254-257.
27. Nagashima T, et al. (2011) Connective tissue growth factor is required for normal follicle development and ovulation. Mol Endocrinol 25(10):1740-1759.
28. Aboura A, et al. (2009) Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure. J Clin Endocrinol Metab 94(11):4540-4546.
29. Wada K, Itoga K, Okano T, Yonemura S, Sasaki H (2011) Hippo pathway regulation by cell morphology and stress fibers. Development 138(18):3907-3914.
30. Boggiano JC, Fehon RG (2012) Growth control by committee: Intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell 22(4):695-702.
31. Bione S, et al. (1998) A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: Evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 62(3):533-541.
32. He C, et al. (2010) A large-scale candidate gene association study of age at menarche and age at natural menopause. Hum Genet 128(5):515-527.
33. Schuh-Huerta SM, et al. (2012) Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women. Hum Reprod 27(2):594-608.
34. Cai J, et al. (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24(21):2383-2388.
35. Muramatsu Y, et al. (2002) Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 62(5):1601-1610.
36. Chaqour B, et al. (2002) Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction. Am J Physiol Endocrinol Metab 283(4):E765-E774.
37. Tumaneng K, et al. (2012) YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol 14(12):1322-1329.
38. Lunde O, Djøseland O, Grøttum P (2001) Polycystic ovarian syndrome: A follow-up study on fertility and menstrual pattern in 149 patients 15-25 years after ovarian wedge resection. Hum Reprod 16(7):1479-1485.
39. van Kasteren YM, Schoemaker J (1999) Premature ovarian failure: A systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 5(5):483-492.
40. Bidet M, et al. (2011) Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 96(12):3864-3872.
41. Broekmans FJ, Soules MR, Fauser BC (2009) Ovarian aging: Mechanisms and clinical consequences. Endocr Rev 30(5):465-493.